Karyopharm Therapeutics Inc. (KPTI) Shareholders’ equity 2016–2025
Karyopharm Therapeutics Inc. (KPTI) shareholders’ equity at each fiscal year-end, per SEC filings.
-$292.9MFY2025 · since FY2016: $162.2M → -$292.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$292.9M | -57.5% |
| FY2024 | -$186.0M | -36.6% |
| FY2023 | -$136.2M | -717.8% |
| FY2022 | -$16.7M | +79.1% |
| FY2021 | -$79.7M | -257.6% |
| FY2020 | $50.5M | +1.6% |
| FY2019 | $49.8M | -72.8% |
| FY2018 | $183.2M | +41.5% |
| FY2017 | $129.5M | -20.2% |
| FY2016 | $162.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice